November 1, 2016
The study titled “Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone” was presented on Saturday October 29th. The primary end-point for the study was non-inferior antimicrobial coverage when compared to the same dose given by intravenous infusion. Antimicrobial coverage refers to time over the Minimum Inhibitory Concentration (MIC), a generally accepted measure of the adequacy of...
Complete bioavailability after subcutaneous administration of ceftriaxone — Equivalent antimicrobial coverage (time over MIC) to standard intravenous administration FOR IMMEDIATE RELEASE: Lexington, MA., October 31, 2016 /PRNewswire/ — scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today the presentation of study results at IDWeek 2016 in New Orleans, Louisiana. The...
Once again this year, Lundbeckfonden is awarding talent prizes to four talented young scientists under the age of 30. All four have made remarkable and promising contributions to research at a very early stage of their careers. “Supporting and contributing to the development of the careers of scientists is one of Lundbeckfonden’s cornerstones. These young...


DNA analysis of 442 Viking skeletons rewrites the story of Viking culture
16. September 2020
Hope that a brain injection could cure type 2 diabetes
7. September 2020
Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge